Use of 5-(2-metoxi-4-[2-(tetrahydro-piran-4-il) -ethylamine]-methyl}-phenyl) -pyridine-2-anthraxamide to treat or prevent conditions associated with peripheral activation of opium receivers, such as opium-induced constipation and opium-induced intestinal dysfunction Eagle.
Use of 5 - (2 - methoxy - 4 - {[2 - (Tetrahydro - piran - 4-yl) ethylamino] methyl} - phenoxy) - 2 - pirazin - carboxamide to Treat or prevent a condition associated with an opioid receptor activation in the PeripheryAs the opioid induced constipation and Bowel dysfunction induced by opioid.<；p>；Uso de 5-(2-metoxi-4-{[2-(tetrahidro-piran-4-il)-etilamino]-metil}-fenoxi)-pirazin-2-carboxamida para tratar o prevenir una condició；n asociada con la activació；n de un receptor opiá；ceo en la periferia tal como el estreñ；imiento inducido por opiá；ceo y la disfunció；n del intestino inducida por opiá；ceo.<；/p>；
